文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

不同目标温度对接受体外膜氧合的院外心脏骤停患者结局的影响:一项全国性队列研究

The impact of different targeted temperatures on out-of-hospital cardiac arrest outcomes in patients receiving extracorporeal membrane oxygenation: a nationwide cohort study.
PubMed 文献 · Crit Care · 2022-12-08
一句话结论在需要ECMO的院外心脏骤停患者中,目标温度35-36°C与32-34°C的30天良好神经结局无差异(16.5% vs 15.9%)。

该研究基于日本急性医学会院外心脏骤停登记数据库(103家参与机构),回顾性分析2014年6月至2019年12月期间890例年龄≥18岁、需要ECMO并接受目标温度管理的院外心脏骤停患者。患者按目标温度分为常温目标温度管理组(35-36°C,n=249)和低温目标温度管理组(32-34°C,n=641)。主要终点为30天生存且神经功能良好(Glasgow-Pittsburgh大脑功能分类评分1或2分)。结果显示两组30天良好神经结局比例分别为16.5%(41/249)和15.9%(102/641),多因素回归分析调整后比值比0.91(95%CI 0.58-1.43),逆概率加权分析比值比1.01(95%CI 0.67-1.54),均无差异。

要点

  • 在需要ECMO的成人院外心脏骤停患者中,目标温度35-36°C与32-34°C的30天良好神经结局比例分别为16.5%(41/249)和15.9%(102/641),无差异。
  • 多因素回归分析显示,常温目标温度管理组与低温目标温度管理组的调整后比值比为0.91(95%CI 0.58-1.43)。
  • 逆概率加权分析结果一致,比值比为1.01(95%CI 0.67-1.54)。
  • 作者认为,无论是否使用ECMO,改变目标温度对患者结局影响甚微这一现有认识可能仍然成立。

适用人群与场景

  • 年龄≥18岁的院外心脏骤停患者,需要ECMO并接受目标温度管理,数据来自日本急性医学会院外心脏骤停登记数据库,2014年6月至2019年12月期间纳入。

诊断标准与关键阈值

  • 良好神经结局定义为Glasgow-Pittsburgh大脑功能分类评分1或2分。
  • 目标温度分组:常温目标温度管理组(35-36°C),低温目标温度管理组(32-34°C)。

研究设计与关键结果

  • 研究类型:基于日本急性医学会院外心脏骤停登记数据库(全国性多中心前瞻性数据库,103家参与机构)的回顾性分析。
  • 共纳入890例接受ECMO和目标温度管理的成人院外心脏骤停患者,其中常温目标温度管理组249例(28%),低温目标温度管理组641例(72%)。
  • 主要终点30天良好神经结局比例:常温目标温度管理组16.5%(41/249),低温目标温度管理组15.9%(102/641)。
  • 多因素回归分析调整后比值比0.91(95%CI 0.58-1.43),无差异。
  • 逆概率加权分析比值比1.01(95%CI 0.67-1.54),结果一致。

证据类型、等级与局限

  • 证据类型:基于全国性多中心前瞻性数据库的回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,无论是否使用ECMO,改变目标温度对患者结局影响甚微这一现有认识可能仍然成立。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Targeted temperature management (TTM) is recommended in the management of out-of-hospital cardiac arrest (OHCA) when coma persists after the return of spontaneous circulation. In the setting of extracorporeal membrane oxygenation (ECMO) for OHCA patients, TTM is associated with good neurological outcomes and is recommended in the Extracorporeal Life Support Organization guidelines. However, the optimal targeted temperature for these patients has not yet been adequately investigated. This study aimed to compare the impact of different targeted temperatures on the outcomes in OHCA patients receiving ECMO.

METHODS: This was a retrospective analysis of data from the Japanese Association for Acute Medicine (JAAM)-OHCA Registry, a multicentre nationwide prospective database in Japan in which 103 institutions providing emergency care participated. OHCA patients aged ≥ 18 years who required ECMO with TTM between June 2014 and December 2019 were included in our analysis. The primary outcome was 30-day survival with favourable neurological outcomes, defined as a Glasgow-Pittsburgh cerebral performance category score of 1 or 2. Patients were divided into two groups according to their targeted temperature: normothermic TTM (n-TTM) (35-36 °C) and hypothermic TTM (h-TTM) (32-34 °C). We compared the outcomes between the two targeted temperature groups using multivariable logistic regression and inverse probability weighting (IPW).

RESULTS: A total of 890 adult OHCA patients who received ECMO and TTM were eligible for our analysis. Of these patients, 249 (28%) and 641 (72%) were treated with n-TTM and h-TTM, respectively. The proportions of patients with 30-day favourable neurological outcomes were 16.5% (41/249) and 15.9% (102/641), in the n-TTM and h-TTM groups, respectively. No difference in neurological outcomes was observed in the multiple regression analysis [adjusted odds ratio 0.91, 95% confidence interval (CI) 0.58-1.43], and the result was constant in the IPW (odds ratio 1.01, 95% CI 0.67-1.54).

CONCLUSION: No difference was observed between n-TTM and h-TTM in OHCA patients receiving TTM with ECMO. The current understanding that changes to the targeted temperature have little impact on the outcome of patients may remain true regardless of ECMO use.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Watanabe M, Matsuyama T, Miyamoto Y, et al. The impact of different targeted temperatures on out-of-hospital cardiac arrest outcomes in patients receiving extracorporeal membrane oxygenation: a nationwide cohort study. Crit Care. 2022. PMID: 36482479. doi:10.1186/s13054-022-04256-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。